Four Stocks Hot In News: Ford Motor Company (NYSE:F), General Motors (NYSE:GM), The Boeing Company (NYSE:BA), Pfizer Inc. (NYSE:PFE)

Ford Motor Company (NYSE:F) the second-largest U.S. automaker, will soon name Mark Fields its next chief executive officer and reveal when current CEO Alan Mulally will retire from the company he is credited with saving, according to two people familiar with the pending announcement.  Ford Motor Company (NYSE:F) shares after opening at $16.01 moved to $16.08 on last trade day and at the end of the day closed at $15.98. Company price to sales ratio in past twelve months was calculated as 0.43 and price to cash ratio as 4.37. Ford Motor Company (NYSE:F) showed a positive weekly performance of 2.24%.

General Motors Company (NYSE:GM), the $54 billion automaker at the center of a massive vehicle recall, moved to assure investors that all was not bad in the company. The company’s president Dan Ammann speaking on Sunday on the sidelines of the auto show in Beijing stated that General Motors has not seen an impact on its Chinese business. General Motors Company (NYSE:GM) ended the day on $33.98. GM return on equity ratio is recorded as 24.60% and its return on assets is 4.70%.  General Motors Company (NYSE:GM) yearly performance is 17.62%.

The Boeing Company (NYSE:BA)’s Defense, Space & Security division reported fiscal 2013 revenue of $33.2 billion, up 2 percent from fiscal 2012. Total earnings from operations were $3.24 billion, up 5 percent. The Boeing Co. reported net earnings for 2013 of $4.59 billion, up 18 percent from fiscal 2012, as the company ended the year with a record backlog of orders.  The Boeing Company (NYSE:BA) shares moved down -0.08% in last trading session and was closed at $127.82 while trading in range of $127.37 – $128.44 – The Boeing Company (NYSE:BA) year to date (YTD) performance is -5.82%.

Pfizer Inc. (NYSE:PFE) the world’s biggest drugmaker, agreed to pay $190 million to end a lawsuit claiming it violated federal antitrust laws by delaying generic versions of its Neurontin epilepsy drug. Pfizer Inc. (NYSE:PFE) weekly performance is 3.35%. On last trading day company shares ended up $30.86.  Pfizer Inc. (NYSE:PFE) distance from 50-day simple moving average (SMA50) is -2.47%. Analysts mean target price for the company is $34.15.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *